A systematic review and novel classification of listing tools to improve medication in older people

[1] Maher RL(2014)Clinical consequences of polypharmacy in elderly Expert Opin Drug Saf 13 57-65

[2] Hanlon J(2012)Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study Lancet 380 37-43

[3] Hajjar ER(2017)Health professional perspectives on the management of multimorbidity and polypharmacy for older patients in Australia Age Ageing 46 291-299

[4] Barnett K(2017)Current and future perspectives on the management of polypharmacy BMC Fam Pract 18 70-1392

[5] Mercer SW(2009)Inappropriate prescribing and adverse drug events in older people BMC Geriatr 9 5-116

[6] Norbury M(2016)Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old Br J Clin Pharmacol 82 1382-782

[7] Watt G(2016)Appropriate polypharmacy and medicine safety: when many is not too many Drug Saf 39 109-738

[8] Wyke S(2014)Inappropriate drug prescribing and polypharmacy are major causes of poor outcomes in long-term care J Am Med Dir Assoc 15 780-377

[9] Guthrie B(2017)Association between polypharmacy and death: a systematic review and meta-analysis J Am Pharm Assoc 57 729-631

[10] Mc Namara KP(2011)Guideline-driven polypharmacy in elderly, multimorbid patients is basically flawed: there are almost no guidelines for these patients J Am Geriatr Soc 59 376-83

[1] Maher RL(2014)Clinical consequences of polypharmacy in elderly Expert Opin Drug Saf 13 57-65

[2] Hanlon J(2012)Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study Lancet 380 37-43

[3] Hajjar ER(2017)Health professional perspectives on the management of multimorbidity and polypharmacy for older patients in Australia Age Ageing 46 291-299

[4] Barnett K(2017)Current and future perspectives on the management of polypharmacy BMC Fam Pract 18 70-1392

[5] Mercer SW(2009)Inappropriate prescribing and adverse drug events in older people BMC Geriatr 9 5-116

[6] Norbury M(2016)Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old Br J Clin Pharmacol 82 1382-782

[7] Watt G(2016)Appropriate polypharmacy and medicine safety: when many is not too many Drug Saf 39 109-738

[8] Wyke S(2014)Inappropriate drug prescribing and polypharmacy are major causes of poor outcomes in long-term care J Am Med Dir Assoc 15 780-377

[9] Guthrie B(2017)Association between polypharmacy and death: a systematic review and meta-analysis J Am Pharm Assoc 57 729-631

[10] Mc Namara KP(2011)Guideline-driven polypharmacy in elderly, multimorbid patients is basically flawed: there are almost no guidelines for these patients J Am Geriatr Soc 59 376-83